|
|
inactivation of mapk activity
|
GO:0000188 |
2 |
1.000
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
13 |
0.999
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
2 |
0.995
|
|
|
|
response to amphetamine
|
GO:0001975 |
25 |
0.994
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
380 |
0.991
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
381 |
0.989
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
33 |
0.987
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
391 |
0.983
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
203 |
0.981
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
252 |
0.979
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
374 |
0.975
|
|
|
|
rna metabolic process
|
GO:0016070 |
406 |
0.970
|
|
|
|
cellular response to mycophenolic acid
|
GO:0071506 |
2 |
0.969
|
|
|
|
collateral sprouting
|
GO:0048668 |
2 |
0.955
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
380 |
0.949
|
|
|
|
transcription dna templated
|
GO:0006351 |
377 |
0.948
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
379 |
0.948
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
75 |
0.945
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
41 |
0.919
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
141 |
0.911
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
5 |
0.907
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
247 |
0.903
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
2 |
0.897
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
4 |
0.888
|
|
|
|
response to camp
|
GO:0051591 |
91 |
0.883
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
234 |
0.876
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
148 |
0.857
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
43 |
0.857
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
123 |
0.834
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
199 |
0.831
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
116 |
0.825
|
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
117 |
0.824
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
161 |
0.824
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
89 |
0.811
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
148 |
0.803
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
20 |
0.797
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
281 |
0.796
|
|
|
|
cell proliferation involved in metanephros development
|
GO:0072203 |
2 |
0.784
|
|
|
|
response to organophosphorus
|
GO:0046683 |
102 |
0.776
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
289 |
0.765
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
4 |
0.752
|
|
|
|
response to amine
|
GO:0014075 |
46 |
0.749
|
|
|
|
circulatory system development
|
GO:0072359 |
134 |
0.744
|
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
267 |
0.733
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
168 |
0.731
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
21 |
0.730
|
|
|
|
response to heparin
|
GO:0071503 |
2 |
0.726
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
387 |
0.715
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
1 |
0.701
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
203 |
0.699
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
334 |
0.690
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
260 |
0.669
|
|
|
|
positive regulation of g0 to g1 transition
|
GO:0070318 |
2 |
0.667
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
48 |
0.662
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
118 |
0.652
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
335 |
0.630
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
319 |
0.628
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
133 |
0.618
|
|
|
|
cellular response to interleukin 1
|
GO:0071347 |
37 |
0.614
|
|
|
|
metanephric nephron development
|
GO:0072210 |
7 |
0.614
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
197 |
0.607
|
|
|
|
response to interleukin 1
|
GO:0070555 |
55 |
0.605
|
|
|
|
regulation of catalytic activity
|
GO:0050790 |
304 |
0.605
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
32 |
0.603
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
27 |
0.603
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
4 |
0.603
|
|
|
|
tissue development
|
GO:0009888 |
252 |
0.586
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
247 |
0.585
|
|
|
|
cellular response to isoquinoline alkaloid
|
GO:0071317 |
6 |
0.584
|
|
|
|
positive regulation of mrna catabolic process
|
GO:0061014 |
2 |
0.583
|
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
197 |
0.579
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
153 |
0.577
|
|
|
|
programmed cell death
|
GO:0012501 |
392 |
0.575
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
319 |
0.571
|
|
|
|
response to catecholamine
|
GO:0071869 |
16 |
0.564
|
|
|
|
interleukin 1 mediated signaling pathway
|
GO:0070498 |
2 |
0.547
|
|
|
|
response to purine containing compound
|
GO:0014074 |
126 |
0.546
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
162 |
0.545
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
161 |
0.542
|
|
|
|
response to acid chemical
|
GO:0001101 |
222 |
0.529
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
244 |
0.526
|
|
|
|
response to oxidative stress
|
GO:0006979 |
186 |
0.517
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
229 |
0.511
|
|
|
|
positive regulation of cell proliferation involved in kidney development
|
GO:1901724 |
4 |
0.507
|
|
|
|
immune system process
|
GO:0002376 |
204 |
0.507
|
|
|
|
response to peptide hormone
|
GO:0043434 |
278 |
0.500
|
|
|
|
neuron death
|
GO:0070997 |
127 |
0.488
|
|
|
|
apoptotic process
|
GO:0006915 |
381 |
0.487
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
17 |
0.483
|
|
|
|
regulation of g0 to g1 transition
|
GO:0070316 |
3 |
0.482
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
4 |
0.481
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.472
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
1 |
0.471
|
|
|
|
glomerular mesangium development
|
GO:0072109 |
4 |
0.469
|
|
|
|
cellular response to lipid
|
GO:0071396 |
201 |
0.466
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
295 |
0.454
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
1 |
0.452
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
197 |
0.446
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
376 |
0.445
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
75 |
0.436
|
|
|
|
response to cold
|
GO:0009409 |
29 |
0.433
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
119 |
0.431
|
|
|
|
mapk cascade
|
GO:0000165 |
140 |
0.431
|
|
|
|
response to peptide
|
GO:1901652 |
292 |
0.429
|
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
4 |
0.427
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
106 |
0.424
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
8 |
0.415
|
|
|
|
regulation of kidney development
|
GO:0090183 |
15 |
0.409
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
349 |
0.402
|
|
|
|
positive regulation of glomerular metanephric mesangial cell proliferation
|
GO:0072303 |
1 |
0.394
|
|
|
|
regulation of cell proliferation involved in kidney development
|
GO:1901722 |
4 |
0.393
|
|
|
|
response to ketone
|
GO:1901654 |
182 |
0.390
|
|
|
|
protein phosphorylation
|
GO:0006468 |
345 |
0.388
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
264 |
0.386
|
|
|
|
response to cytokine
|
GO:0034097 |
215 |
0.386
|
|
|
|
response to mycophenolic acid
|
GO:0071505 |
2 |
0.382
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
134 |
0.381
|
|
|
|
cellular response to cycloheximide
|
GO:0071409 |
4 |
0.379
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
331 |
0.372
|
|
|
|
regulation of molecular function
|
GO:0065009 |
398 |
0.372
|
|
|
|
regulation of mrna 3 end processing
|
GO:0031440 |
1 |
0.371
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
3 |
0.371
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
144 |
0.367
|
|
|
|
chemotaxis
|
GO:0006935 |
66 |
0.356
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
123 |
0.350
|
|
|
|
t cell differentiation
|
GO:0030217 |
9 |
0.350
|
|
|
|
cellular response to stress
|
GO:0033554 |
269 |
0.345
|
|
|
|
neurological system process
|
GO:0050877 |
219 |
0.342
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
117 |
0.340
|
|
|
|
regulation of protein modification process
|
GO:0031399 |
194 |
0.338
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
45 |
0.336
|
|
|
|
dephosphorylation
|
GO:0016311 |
98 |
0.333
|
|
|
|
response to light stimulus
|
GO:0009416 |
52 |
0.333
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
154 |
0.332
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
49 |
0.321
|
|
|
|
rhythmic process
|
GO:0048511 |
156 |
0.321
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
194 |
0.321
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
377 |
0.317
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
81 |
0.315
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
2 |
0.313
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
157 |
0.303
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
127 |
0.302
|
|
|
|
cellular response to camp
|
GO:0071320 |
26 |
0.301
|
|
|
|
response to other organism
|
GO:0051707 |
220 |
0.299
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
83 |
0.299
|
|
|
|
reproductive process
|
GO:0022414 |
372 |
0.296
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
88 |
0.293
|
|
|
|
response to bacterium
|
GO:0009617 |
200 |
0.293
|
|
|
|
negative regulation of oligodendrocyte differentiation
|
GO:0048715 |
3 |
0.291
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
120 |
0.288
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
3 |
0.287
|
|
|
|
eye development
|
GO:0001654 |
50 |
0.285
|
|
|
|
response to isoquinoline alkaloid
|
GO:0014072 |
28 |
0.282
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
270 |
0.282
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
183 |
0.281
|
|
|
|
immune system development
|
GO:0002520 |
41 |
0.277
|
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
1 |
0.276
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
223 |
0.272
|
|
|
|
anatomical structure morphogenesis
|
GO:0009653 |
298 |
0.272
|
|
|
|
neuron development
|
GO:0048666 |
286 |
0.269
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
341 |
0.267
|
|
|
|
behavior
|
GO:0007610 |
205 |
0.264
|
|
|
|
taxis
|
GO:0042330 |
67 |
0.264
|
|
|
|
response to growth factor
|
GO:0070848 |
189 |
0.261
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
105 |
0.258
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
181 |
0.257
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
359 |
0.255
|
|
|
|
circadian rhythm
|
GO:0007623 |
88 |
0.254
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
1 |
0.251
|
|
|
|
neuron differentiation
|
GO:0030182 |
368 |
0.250
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
318 |
0.249
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
71 |
0.249
|
|
|
|
response to alkaloid
|
GO:0043279 |
132 |
0.241
|
|
|
|
response to follicle stimulating hormone
|
GO:0032354 |
18 |
0.240
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
380 |
0.238
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
184 |
0.237
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
20 |
0.236
|
|
|
|
response to corticosterone
|
GO:0051412 |
40 |
0.234
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
2 |
0.233
|
|
|
|
response to inorganic substance
|
GO:0010035 |
377 |
0.229
|
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
184 |
0.228
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
152 |
0.227
|
|
|
|
blood vessel development
|
GO:0001568 |
69 |
0.224
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
79 |
0.223
|
|
|
|
response to radiation
|
GO:0009314 |
137 |
0.221
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
155 |
0.216
|
|
|
|
t cell activation
|
GO:0042110 |
29 |
0.215
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
116 |
0.215
|
|
|
|
response to gamma radiation
|
GO:0010332 |
24 |
0.207
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
64 |
0.206
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
10 |
0.205
|
|
|
|
response to calcium ion
|
GO:0051592 |
59 |
0.203
|
|
|
|
cellular response to alkaloid
|
GO:0071312 |
25 |
0.202
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
11 |
0.202
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
7 |
0.200
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
1 |
0.200
|
|
|
|
response to nutrient levels
|
GO:0031667 |
370 |
0.200
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
114 |
0.199
|
|
|
|
nephron development
|
GO:0072006 |
22 |
0.197
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
80 |
0.197
|
|
|
|
regulation of protein phosphorylation
|
GO:0001932 |
183 |
0.197
|
|
|
|
response to ethanol
|
GO:0045471 |
162 |
0.195
|
|
|
|
axonogenesis
|
GO:0007409 |
71 |
0.194
|
|
|
|
metanephric glomerulus vasculature development
|
GO:0072239 |
1 |
0.191
|
|
|
|
response to toxic substance
|
GO:0009636 |
133 |
0.189
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
1 |
0.189
|
|
|
|
circadian behavior
|
GO:0048512 |
24 |
0.185
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
1 |
0.184
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
248 |
0.182
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
386 |
0.179
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
134 |
0.178
|
|
|
|
cell projection organization
|
GO:0030030 |
302 |
0.173
|
|
|
|
neuron projection development
|
GO:0031175 |
273 |
0.172
|
|
|
|
learning or memory
|
GO:0007611 |
90 |
0.170
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
120 |
0.168
|
|
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
6 |
0.166
|
|
|
|
positive regulation of glomerular mesangial cell proliferation
|
GO:0072126 |
4 |
0.164
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
4 |
0.164
|
|
|
|
regulation of natural killer cell mediated immune response to tumor cell
|
GO:0002855 |
1 |
0.163
|
|
|
|
aging
|
GO:0007568 |
241 |
0.160
|
|
|
|
response to wounding
|
GO:0009611 |
254 |
0.157
|
|
|
|
growth
|
GO:0040007 |
165 |
0.153
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
349 |
0.152
|
|
|
|
single organism reproductive process
|
GO:0044702 |
297 |
0.152
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
218 |
0.149
|
|
|
|
wound healing
|
GO:0042060 |
122 |
0.146
|
|
|
|
response to cycloheximide
|
GO:0046898 |
6 |
0.146
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
314 |
0.145
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
10 |
0.144
|
|
|
|
central nervous system development
|
GO:0007417 |
311 |
0.137
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
1 |
0.137
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
346 |
0.136
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
202 |
0.136
|
|
|
|
response to insulin
|
GO:0032868 |
133 |
0.135
|
|
|
|
rhythmic behavior
|
GO:0007622 |
24 |
0.134
|
|
|
|
glial cell differentiation
|
GO:0010001 |
65 |
0.134
|
|
|
|
connective tissue development
|
GO:0061448 |
33 |
0.133
|
|
|
|
protein dephosphorylation
|
GO:0006470 |
38 |
0.132
|
|
|
|
cellular response to drug
|
GO:0035690 |
30 |
0.130
|
|
|
|
mrna stabilization
|
GO:0048255 |
2 |
0.129
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
283 |
0.128
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
226 |
0.126
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
83 |
0.126
|
|
|
|
response to estradiol
|
GO:0032355 |
164 |
0.126
|
|
|
|
positive regulation of glomerulus development
|
GO:0090193 |
4 |
0.125
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
106 |
0.125
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
237 |
0.124
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
197 |
0.123
|
|
|
|
kidney vasculature development
|
GO:0061440 |
6 |
0.117
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
35 |
0.116
|
|
|
|
regulation of neuron death
|
GO:1901214 |
115 |
0.114
|
|
|
|
regulation of cell development
|
GO:0060284 |
263 |
0.112
|
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
155 |
0.111
|
|
|
|
response to carbon monoxide
|
GO:0034465 |
4 |
0.110
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
221 |
0.110
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
217 |
0.109
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
138 |
0.108
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
249 |
0.108
|
|
|
|
secretion
|
GO:0046903 |
307 |
0.104
|
|
|
|
response to ammonium ion
|
GO:0060359 |
71 |
0.103
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
41 |
0.103
|
|
|
|
cell morphogenesis
|
GO:0000902 |
142 |
0.102
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
271 |
0.101
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
80 |
0.096
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
181 |
0.095
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
178 |
0.095
|
|
|
|
facial nerve development
|
GO:0021561 |
1 |
0.092
|
|
|
|
viral transcription
|
GO:0019083 |
2 |
0.091
|
|
|
|
glomerulus development
|
GO:0032835 |
10 |
0.090
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
93 |
0.090
|
|
|
|
response to cocaine
|
GO:0042220 |
39 |
0.090
|
|
|
|
regulation of catabolic process
|
GO:0009894 |
113 |
0.089
|
|
|
|
sensory organ development
|
GO:0007423 |
74 |
0.089
|
|
|
|
axon development
|
GO:0061564 |
96 |
0.088
|
|
|
|
d amino acid transport
|
GO:0042940 |
1 |
0.087
|
|
|
|
negative regulation of erk1 and erk2 cascade
|
GO:0070373 |
9 |
0.087
|
|
|
|
protein localization
|
GO:0008104 |
191 |
0.087
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
247 |
0.085
|
|
|
|
response to estrogen
|
GO:0043627 |
232 |
0.085
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
163 |
0.084
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
262 |
0.082
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
4 |
0.082
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
123 |
0.082
|
|
|
|
protein sumoylation
|
GO:0016925 |
4 |
0.080
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
123 |
0.078
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
191 |
0.077
|
|
|
|
locomotor rhythm
|
GO:0045475 |
1 |
0.076
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
90 |
0.076
|
|
|
|
rhombomere development
|
GO:0021546 |
1 |
0.076
|
|
|
|
cognition
|
GO:0050890 |
92 |
0.075
|
|
|
|
developmental growth
|
GO:0048589 |
100 |
0.074
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
106 |
0.073
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
2 |
0.073
|
|
|
|
axon regeneration
|
GO:0031103 |
28 |
0.073
|
|
|
|
gliogenesis
|
GO:0042063 |
93 |
0.073
|
|
|
|
protein transport
|
GO:0015031 |
132 |
0.072
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
233 |
0.071
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
36 |
0.071
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
99 |
0.071
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
58 |
0.070
|
|
|
|
leukocyte activation
|
GO:0045321 |
76 |
0.070
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
4 |
0.070
|
|
|
|
vasculature development
|
GO:0001944 |
70 |
0.070
|
|
|
|
cellular component assembly
|
GO:0022607 |
360 |
0.070
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
18 |
0.069
|
|
|
|
muscle tissue development
|
GO:0060537 |
58 |
0.069
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
320 |
0.066
|
|
|
|
response to electrical stimulus
|
GO:0051602 |
56 |
0.066
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
49 |
0.066
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
43 |
0.065
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
122 |
0.064
|
|
|
|
response to corticosteroid
|
GO:0031960 |
235 |
0.063
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
116 |
0.063
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
122 |
0.063
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
44 |
0.063
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
125 |
0.063
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
7 |
0.062
|
|
|
|
learning
|
GO:0007612 |
33 |
0.062
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
83 |
0.061
|
|
|
|
response to metal ion
|
GO:0010038 |
253 |
0.061
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
12 |
0.061
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
6 |
0.061
|
|
|
|
cellular response to peptide
|
GO:1901653 |
133 |
0.060
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
69 |
0.060
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
368 |
0.059
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
33 |
0.059
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
53 |
0.059
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
1 |
0.058
|
|
|
|
response to oxygen levels
|
GO:0070482 |
265 |
0.058
|
|
|
|
regulation of rna stability
|
GO:0043487 |
3 |
0.058
|
|
|
|
regulation of immune system process
|
GO:0002682 |
123 |
0.058
|
|
|
|
regulation of system process
|
GO:0044057 |
208 |
0.058
|
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
262 |
0.057
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
29 |
0.057
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
62 |
0.057
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
94 |
0.056
|
|
|
|
response to retinoic acid
|
GO:0032526 |
63 |
0.056
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
12 |
0.056
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
316 |
0.055
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
292 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
30 |
0.055
|
|
|
|
response to glucose
|
GO:0009749 |
136 |
0.054
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
12 |
0.054
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
233 |
0.054
|
|
|
|
response to muramyl dipeptide
|
GO:0032495 |
1 |
0.053
|
|
|
|
endocytosis
|
GO:0006897 |
84 |
0.053
|
|
|
|
regulation of dna methylation
|
GO:0044030 |
6 |
0.053
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
29 |
0.052
|
|
|
|
muscle structure development
|
GO:0061061 |
87 |
0.052
|
|
|
|
sleep
|
GO:0030431 |
30 |
0.051
|
|
|
|
single organism behavior
|
GO:0044708 |
130 |
0.051
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
158 |
0.051
|
|
|
|
phagocytosis
|
GO:0006909 |
17 |
0.051
|
|
|
|
metanephros development
|
GO:0001656 |
14 |
0.050
|
|
|
|
positive regulation of nitric oxide biosynthetic process
|
GO:0045429 |
14 |
0.050
|
|
|
|
heart process
|
GO:0003015 |
57 |
0.050
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
165 |
0.050
|
|
|
|
response to peptidoglycan
|
GO:0032494 |
1 |
0.049
|
|
|
|
photoperiodism
|
GO:0009648 |
4 |
0.049
|
|
|
|
rna catabolic process
|
GO:0006401 |
3 |
0.049
|
|
|
|
renal system development
|
GO:0072001 |
67 |
0.048
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
51 |
0.048
|
|
|
|
embryo development
|
GO:0009790 |
49 |
0.047
|
|
|
|
skeletal muscle tissue development
|
GO:0007519 |
31 |
0.047
|
|
|
|
negative regulation of cell migration involved in sprouting angiogenesis
|
GO:0090051 |
1 |
0.047
|
|
|
|
tube development
|
GO:0035295 |
89 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
101 |
0.047
|
|
|
|
sexual reproduction
|
GO:0019953 |
148 |
0.045
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
17 |
0.045
|
|
|
|
organ regeneration
|
GO:0031100 |
101 |
0.045
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
23 |
0.045
|
|
|
|
lymphocyte activation
|
GO:0046649 |
43 |
0.045
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
229 |
0.045
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
52 |
0.044
|
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
11 |
0.044
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
136 |
0.043
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
182 |
0.043
|
|
|
|
response to gonadotropin
|
GO:0034698 |
34 |
0.042
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
283 |
0.042
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
4 |
0.042
|
|
|
|
establishment of protein localization
|
GO:0045184 |
141 |
0.041
|
|
|
|
feeding behavior
|
GO:0007631 |
53 |
0.041
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
51 |
0.041
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.041
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
136 |
0.041
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
45 |
0.041
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
13 |
0.041
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
176 |
0.041
|
|
|
|
associative learning
|
GO:0008306 |
19 |
0.041
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
13 |
0.041
|
|
|
|
response to testosterone
|
GO:0033574 |
55 |
0.041
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
2 |
0.040
|
|
|
|
regulation of synaptic transmission
|
GO:0050804 |
141 |
0.040
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
78 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
179 |
0.039
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
46 |
0.039
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
2 |
0.039
|
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
178 |
0.039
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
200 |
0.039
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
48 |
0.038
|
|
|
|
reproduction
|
GO:0000003 |
245 |
0.038
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
157 |
0.038
|
|
|
|
transforming growth factor beta3 production
|
GO:0032907 |
2 |
0.038
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
3 |
0.038
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
342 |
0.037
|
|
|
|
kidney development
|
GO:0001822 |
67 |
0.037
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
56 |
0.036
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
3 |
0.036
|
|
|
|
organ senescence
|
GO:0010260 |
2 |
0.036
|
|
|
|
synaptic transmission
|
GO:0007268 |
235 |
0.036
|
|
|
|
cellular catabolic process
|
GO:0044248 |
295 |
0.036
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
57 |
0.036
|
|
|
|
jak stat cascade
|
GO:0007259 |
26 |
0.036
|
|
|
|
positive regulation of cellular protein metabolic process
|
GO:0032270 |
167 |
0.036
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
38 |
0.035
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
31 |
0.035
|
|
|
|
response to norepinephrine
|
GO:0071873 |
5 |
0.035
|
|
|
|
hemopoiesis
|
GO:0030097 |
34 |
0.035
|
|
|
|
response to axon injury
|
GO:0048678 |
59 |
0.035
|
|
|
|
gtp catabolic process
|
GO:0006184 |
71 |
0.034
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
1 |
0.034
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
48 |
0.033
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
78 |
0.033
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
285 |
0.033
|
|
|
|
dna metabolic process
|
GO:0006259 |
96 |
0.033
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
38 |
0.033
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
118 |
0.033
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
86 |
0.032
|
|
|
|
epiboly involved in wound healing
|
GO:0090505 |
2 |
0.032
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
85 |
0.031
|
|
|
|
placenta development
|
GO:0001890 |
22 |
0.030
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
84 |
0.030
|
|
|
|
localization of cell
|
GO:0051674 |
202 |
0.030
|
|
|
|
response to morphine
|
GO:0043278 |
27 |
0.030
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
13 |
0.030
|
|
|
|
macromolecule localization
|
GO:0033036 |
252 |
0.030
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
59 |
0.029
|
|
|
|
urogenital system development
|
GO:0001655 |
78 |
0.029
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
159 |
0.029
|
|
|
|
gamete generation
|
GO:0007276 |
124 |
0.029
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
16 |
0.029
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
316 |
0.028
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
4 |
0.028
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
3 |
0.028
|
|
|
|
entrainment of circadian clock
|
GO:0009649 |
3 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
36 |
0.028
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
52 |
0.028
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
18 |
0.028
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
167 |
0.027
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
13 |
0.027
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
17 |
0.027
|
|
|
|
response to carbohydrate
|
GO:0009743 |
183 |
0.027
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
115 |
0.027
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.027
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
135 |
0.027
|
|
|
|
regulation of protein processing
|
GO:0070613 |
50 |
0.027
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
23 |
0.027
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
29 |
0.027
|
|
|
|
cell cell signaling
|
GO:0007267 |
335 |
0.026
|
|
|
|
interleukin 6 production
|
GO:0032635 |
12 |
0.026
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
42 |
0.026
|
|
|
|
circulatory system process
|
GO:0003013 |
183 |
0.026
|
|
|
|
response to monoamine
|
GO:0071867 |
17 |
0.026
|
|
|
|
regulation of telomerase activity
|
GO:0051972 |
2 |
0.026
|
|
|
|
regeneration
|
GO:0031099 |
163 |
0.025
|
|
|
|
cardiovascular system development
|
GO:0072358 |
134 |
0.025
|
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
262 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
174 |
0.025
|
|
|
|
proteolysis
|
GO:0006508 |
175 |
0.025
|
|
|
|
p38mapk cascade
|
GO:0038066 |
1 |
0.024
|
|
|
|
mrna processing
|
GO:0006397 |
14 |
0.024
|
|
|
|
regulation of long term neuronal synaptic plasticity
|
GO:0048169 |
15 |
0.024
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
60 |
0.024
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
71 |
0.024
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
55 |
0.024
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
31 |
0.024
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
118 |
0.024
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
46 |
0.024
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
103 |
0.023
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
7 |
0.023
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
28 |
0.023
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
119 |
0.023
|
|
|
|
negative regulation of muscle hyperplasia
|
GO:0014740 |
1 |
0.023
|
|
|
|
response to monosaccharide
|
GO:0034284 |
159 |
0.023
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
3 |
0.023
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
227 |
0.022
|
|
|
|
rna stabilization
|
GO:0043489 |
2 |
0.022
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
39 |
0.022
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
1 |
0.022
|
|
|
|
regulation of ossification
|
GO:0030278 |
32 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
37 |
0.022
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
29 |
0.022
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
10 |
0.022
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
38 |
0.022
|
|
|
|
cytoskeleton organization
|
GO:0007010 |
111 |
0.022
|
|
